Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Boehringer Ingelheim Pharma develops aldosterone synthase inhibitors

April 29, 2016

FDA accepts OPKO's resubmitted NDA for calcifediol

April 28, 2016

FDA grants fast track designation for recAP in acute kidney injury

April 27, 2016

Boehringer Ingelheim initiates phase I study of anti-CX3CR1 Nanobody from Ablynx alliance

April 21, 2016

TGI and Quark enter discovery and development collaboration

April 15, 2016

Eli Lilly develops PDE4B inhibitors

April 4, 2016

Kyorin and Kissei sign codevelopment and co-marketing agreement for KRP-114V in Japan

March 31, 2016

Positive topline results from pivotal phase III study of ferric citrate

March 30, 2016

First patients dosed in Quark Pharmaceuticals' pivotal studies

March 15, 2016

Astellas Pharma discloses muscarinic M3 receptor PAMs

March 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...